Cedric Francois - 25 Apr 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Chief Executive Officer, Director
Signature: /s/ David Watson, attorney-in-fact for Cedric Francois
Issuer symbol: APLS
Transactions as of: 25 Apr 2022
Net transactions value: +$6,903,357
Form type: 4
Filing time: 17 Jan 2023, 18:37:25 UTC
Previous filing: 14 Feb 2022
Next filing: 24 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Award	$0	+83,447	+8.6%	$0.000000	1,048,575	12 Jan 2023	Direct	F1
holding	APLS	Common Stock						300,000	25 Apr 2022	The Francois Grossi Trust	F2
holding	APLS	Common Stock						234,411	25 Apr 2022	The Francois-DuBois Educational Trust	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Other	$0	-75,000	-100%	$0.000000^*	0	25 Apr 2022	Common Stock	75,000	$44.90	Direct	F4, F5
transaction	APLS	Stock Option (Right to Buy)	Award	$6,903,357	+131,093		$52.66	131,093	12 Jan 2023	Common Stock	131,093	$52.66	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This represents a Restricted Stock Award granted 01/12/23 that vest annually from grant date over a four year period subject to continued service.
F2	The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
F3	The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
F4	This represents the cancellation of a performance stock option granted on 01/28/2021. The performance metrics were not met.
F5	This stock option will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to the satisfaction of a specified performance condition and continued service.
F6	This represents a stock option award granted 01/12/2023 that vest over a four year period. 25% vest one year from grant date and the remaining 75% vest monthly thereafter subject to continued service.